AI-Driven Drug Discovery: Target-Specific Molecule Generation for Cancer Pathways
The Target Specific module within the SyMoG/AI application represents a groundbreaking approach to synthetic molecule generation tailored to specific biological targets, focusing on drug discovery for cancer-related pathways. Leveraging machine learning models trained on active and inactive molecular representations (SMILES), the module facilitates identifying and creating molecules with desired properties.